Woodline Partners LP Guardant Health, Inc. Transaction History

Woodline Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$22.92 - $33.76 $1.04 Million - $1.53 Million	45,370 New	45,370 $1.06 Million
Q3 2021 Nov 15, 2021	SELL	$98.77 - $132.17 $3.58 Million - $4.79 Million	-36,210 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $1.1 Million - $1.66 Million	9,997 Added 38.14%	36,210 $4.5 Million
Q1 2021 May 17, 2021	BUY	$127.04 - $179.1 $301,084 - $424,467	2,370 Added 9.94%	26,213 $4 Million
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $2.38 Million - $3.24 Million	23,843 New	23,843 $3.07 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.